Atopic Dermatitis Biomarkers and the Movement Toward Personalized Treatment

Shahzeb Hassan, Noor Hamideh, Christian Poulos, Sarah Cheema, Sean Rangwani, Peter A. Lio

Research output: Contribution to journalArticlepeer-review

Abstract

Atopic dermatitis (AD) is a heterogeneous disorder with varying phenotypes. Although AD has long been associated with barrier dysfunction, the pathogenesis of this disease is more complex, involving many molecular markers in different functional domains. Biomarkers can be helpful in different ways, including predicting prognosis, measuring treatment response, and gauging disease severity. With the advent of targeted immunomodulators, biomarkers have the potential to take on new significance in terms of selecting appropriate therapies for patients. In this review, we have summarized the key findings related to biomarkers and AD, including the specific subtype differences. Clinicians will use this information to better understand the potential of biomarkers in AD and have a guide because more specific treatments are developed that are tailored toward individual molecular profiles.

Original languageEnglish (US)
Pages (from-to)S8-S14
JournalDermatitis : contact, atopic, occupational, drug
Volume32
Issue number1
DOIs
StatePublished - Oct 1 2021

ASJC Scopus subject areas

  • Immunology and Allergy
  • Dermatology

Fingerprint

Dive into the research topics of 'Atopic Dermatitis Biomarkers and the Movement Toward Personalized Treatment'. Together they form a unique fingerprint.

Cite this